O'Brien, M., Cronin, A., Fearn, P., Smith, B., Stasi, J., Guillonneau, B., . . . Lilja, H. (2009). Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
Chicago Style (17th ed.) CitationO'Brien, M., et al. Pretreatment Prostate-specific Antigen (PSA) Velocity and Doubling Time Are Associated with Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated with Radical Prostatectomy. 2009.
MLA citiranjeO'Brien, M., et al. Pretreatment Prostate-specific Antigen (PSA) Velocity and Doubling Time Are Associated with Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated with Radical Prostatectomy. 2009.